为癌症免疫疗法设计一种弹性控制器:应用于分数顺序的瘤免疫模型
Mohamadreza Homayounzade1, Shayan Sajadian1
1Mechanical Engineering Department, Fasa University, Fasa, Iran.
IET systems biology
|June 5, 2025
概括
这项研究引入了抗血管性分子疗法的强有力的控制方法,成功地根除瘤,同时保持健康的细胞和安全的药物水平. 这种方法确保精确控制瘤体积的减少,以有效治疗癌症.
科学领域:
- 生物医学工程 生物医学工程
- 控制理论 控制理论
- 计算生物学 计算生物学
背景情况:
- 癌症治疗面临的挑战是有效地根除瘤,同时尽量减少对健康组织的损害.
- 向分子疗法需要精确的控制来优化药物剂量并保持自然免疫反应.
研究的目的:
- 开发一种强大的控制方法,用于自动化抗血管生成分子疗法.
- 确保瘤细胞的根除,效应细胞的保存和安全的药物剂量.
- 为了精确控制瘤体积收率.
主要方法:
- 使用多输入多输出 (MIMO) 非线性分数和非分数模型.
- 使用后退 (BS) 控制方法.
- 应用了莱普诺夫定理来验证稳定性和强度.
- 集成了一个来自深度强化学习 (DRL) 的软演员-关键 (SAC) 算法,用于控制器调整.
主要成果:
- 使用Lyapunov定理证明了受控系统的指数稳定性.
- 实现了对瘤体积收率的精确控制.
- 通过利亚普诺夫定理对参数不确定性的系统稳定性进行验证.
- 拟议的方案在长期性能方面超过了最先进的方法.
结论:
- 开发的控制方法能够在50天内彻底根除瘤.
- 该疗法成功地维持了高效细胞水平,并使药物输送达到零.
- 这种强大的控制策略为自动化癌症治疗提供了有希望的进步.
相关概念视频
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Adaptive Mechanisms in Cancer Cells
6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K


